Bausch Health (BHC) Q4 Earnings Lag Estimates

分组1 - Bausch Health reported quarterly earnings of $1.08 per share, missing the Zacks Consensus Estimate of $1.21 per share, and showing a decrease from $1.15 per share a year ago, resulting in an earnings surprise of -10.50% [1] - The company posted revenues of $2.8 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.38%, and an increase from $2.56 billion year-over-year [2] - Bausch has surpassed consensus revenue estimates three times over the last four quarters, while it has only surpassed consensus EPS estimates once in the same period [2] 分组2 - The stock has underperformed the market, losing about 13.8% since the beginning of the year, compared to the S&P 500's zero return [3] - The current consensus EPS estimate for the coming quarter is $0.82 on revenues of $2.43 billion, and for the current fiscal year, it is $4.07 on revenues of $10.49 billion [7] - The Medical - Generic Drugs industry, to which Bausch belongs, is currently in the bottom 20% of the Zacks Industry Rank, indicating potential challenges for stock performance [8]